Home » Topics » Regulatory

Regulatory
RSS

FDA approves beta-blocker-free, fixed-combination therapy for glaucoma

April 23, 2013

Hydrea approved for essential thrombocythemia and polycythemia vera in Japan

April 4, 2013

Neoral receives an additional indication approval in Japan

April 3, 2013

Istradefylline approved in Japan for Parkinson's disease

April 3, 2013

Invokana approved by the FDA for type 2 diabetes

April 2, 2013

Eisai obtains FDA approval for new formulation of AcipHex

April 2, 2013

FDA approves Biogen Idec's Tecfidera as first-line oral treatment for MS

March 28, 2013

FDA approves botulism antitoxin manufactured by Cangene

March 27, 2013

Chugai gains Japanese approval for subcutaneous formulation of Actemra

March 27, 2013

Shionogi receives approval for metreleptin in Japan

March 27, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...